Immunome Inc

NASDAQ:IMNM   3:59:51 PM EDT
3.47
+0.22 (+6.77%)
Earnings Announcements

Immunome Q4 Loss Per Share $0.65

Published: 03/28/2022 12:19 GMT
Immunome Inc (IMNM) - Immunome Reports Fourth Quarter and Full Year 2021 Financial Results.
Q4 Loss per Share $0.65.
As of December 31, 2021, Cash and Cash Equivalents Totaled $49.2 Million.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.75

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.82

More details on our Analysts Page.